Darbepoetin alfa biosimilar (JCR Pharmaceuticals/Kissei Pharmaceutical)

阿法达贝泊汀生物类似药 (JCR Pharmaceuticals/Kissei Pharmaceutical)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDarbepoetin alfa biosimilar (JCR Pharmaceuticals/Kissei Pharmaceutical)
Drug Alias Name达促红素α生物仿制药 (JCR Pharmaceuticals/Kissei Pharmaceutical)达依泊汀α生物仿制药 (JCR Pharmaceuticals/Kissei Pharmaceutical)达贝泊汀α生物仿制药 (JCR Pharmaceuticals/Kissei Pharmaceutical)阿法达贝汀生物仿制药 (JCR Pharmaceuticals/Kissei Pharmaceutical)阿法达贝泊汀生物仿制药 (JCR Pharmaceuticals/Kissei Pharmaceutical) +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsAnemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2019/09/20
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesJcr Pharmaceuticals Co LtdKissei Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJcr Pharmaceuticals Co Ltd
Inactive CompaniesKissei Pharmaceutical Co Ltd
Active IndicationsAnemia
Inactive IndicationsN/A

Other Information

ATC CodeB03XA02
Related LinksN/A